BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20241206T100000
DTEND;TZID=Asia/Shanghai:20241208T160000
DTSTAMP:20260508T161216
CREATED:20241007T161712Z
LAST-MODIFIED:20250608T081755Z
UID:10000015-1733479200-1733673600@oncodaily.com
SUMMARY:ESMO Asia Congress 2024
DESCRIPTION:The ESMO Asia Congress 2024 will be held at the Suntec Singapore Convention & Exhibition Centre\, Singapore\, on December 6-8. It is organized by the European Society for Medical Oncology. \nThis key event brings together oncologists\, researchers\, and healthcare professionals from Asia and beyond to share the latest in cancer research\, clinical trials\, and treatment strategies. \nAttendees can look forward to a range of scientific sessions covering key topics in oncology\, including new research findings and innovative treatment approaches. There will also be educational sessions aimed at providing practical insights that participants can apply in their everyday practice. \nDon’t miss this opportunity to connect with peers and shape the future of cancer care in the region! \nRegister here. \nFind more information featuring the Congress at OncoDaily.com.
URL:https://oncodaily.com/event/159674
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard\, Suntec City\, 039593\, Singapore
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/ESMO-ASIA-Congress-2024-FB-LI-1200x628-Register.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241211T080000
DTEND;TZID=Europe/Helsinki:20241213T160000
DTSTAMP:20260508T161216
CREATED:20241007T163026Z
LAST-MODIFIED:20250608T081714Z
UID:10000016-1733904000-1734105600@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2024
DESCRIPTION:Join the ESMO Immuno-Oncology Congress 2024\, happening in Palexpo exhibition Centre in Geneva\, Switzerland\, and online on 11-13 December. This international event features a comprehensive educational program and highlights the latest scientific advancements in the rapidly evolving field of immunotherapy. It is organized by the European Society for Medical Oncology. \nWhether you’re looking to grasp the fundamentals of immunotherapies or delve into cutting-edge research\, this congress will address a wide range of topics—from treatment options to managing toxicities and interpreting new data. It’s designed to meet the diverse needs of all oncology stakeholders. \nDon’t miss this opportunity to learn\, share your research\, and connect with leaders who are shaping the future of cancer treatment. Find the registration link here. \nMore information featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/159712
LOCATION:Palexpo exhibition centre\, 30 Route François-Peyrot \, Geneva\, 1218\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Vignette-agenda-Palexpo-12.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241217T180000
DTEND;TZID=America/Halifax:20241217T190000
DTSTAMP:20260508T161216
CREATED:20241129T195622Z
LAST-MODIFIED:20250608T082031Z
UID:10000081-1734458400-1734462000@oncodaily.com
SUMMARY:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC
DESCRIPTION:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th\, 2024. \nJoin this Live Webinar on advancements in gastrointestinal (GI) cancer care\, featuring experts Van Cutsem Eric\, Neuzillet Cindy\, and Ruiz-Garcia Erika. The event will explore recent breakthroughs in minimally invasive surgery\, targeted therapies\, and immunotherapy\, which are improving survival rates. The speakers will discuss how molecular insights are driving personalized treatment and transforming patient outcomes. Don’t miss this opportunity to learn about the latest developments and future directions in GI cancer care. \nThe webinar will begin with an introduction by Eric Van Cutsem (BE)\, setting the stage for the discussions on the latest advancements in immuno-oncology for gastrointestinal cancers. Cindy Neuzillet (FR) will then present on the progress of immuno-oncology in biliary and pancreatic cancers\, highlighting the most recent breakthroughs and clinical developments in these challenging and often difficult-to-treat cancers. Following this\, Erika Ruiz Garcia (MX) will focus on the advances in immuno-oncology for colorectal and stomach cancer\, exploring how emerging therapies are improving outcomes for patients with these common malignancies. \nAfter the presentations\, there will be an open discussion and Q&A session\, where attendees can engage directly with the speakers\, ask questions\, and share insights. The webinar will conclude with closing remarks from Eric Van Cutsem (BE)\, summarizing the key points discussed and providing a forward-looking perspective on the future of immuno-oncology in GI cancer care. This session promises to be an informative and interactive opportunity for healthcare professionals and researchers to learn about the latest advancements in this rapidly evolving field. \nLink to register and access the session. \n 
URL:https://oncodaily.com/event/194185
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_17_Dec_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
END:VCALENDAR